The competitive startup world can be a strange place for a new medication to proliferate, Chastain points out, because of the pressure from venture capital investors to scale
There is now growing appreciation that kidney impairment can develop in people with diabetes in the absence of increasing albuminuria and in the presence of other nondiabetes-related causes of CKD
But you might still qualify if you have the right documented health condition
People who combine GLP-1 medications with other weight management compounds should be especially careful about frequency and timing
(Not to mention the price tag.) Ive checked in a couple of times since then, most recently in the autumn, but this update feels different because this time, I walked out of my doctors office with the best news Ive gotten in years
The SURMOUNT-1 trial evaluating tirzepatide for obesity demonstrated even greater weight reductions, with participants losing up to 20% of body weight at the highest dose